Project Details
Description
A Phase II Study of Fulvestrant (Faslodex) in the Treatment of Recurrent Ovarian Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/06 → 12/31/09 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.